152 Search Results for: manufacturing

TC Biopharm Extends Space at Maxim Park

Maxim Park has announced that tenant TC BioPharm (TCB) has extended its space at the Park by an additional 10,000 sq ft, on a ten-year lease, within the Maxim 1 building. The immunotherapy company has been a tenant at the Park since 2014, when it took 5,000 sq ft on an initial ten-year lease to build facilities for the development of novel treatments for various...

Strathclyde Chemistry student strikes gold at Westminster

A postgraduate Chemistry student at the University of Strathclyde has struck gold in a competition in the House of Commons, for the excellence of his research. David Fallon was the winner in the Chemistry category of STEM for BRITAIN, a UK-wide competition run by the Parliamentary & Scientific Committee. He presented his chemistry research, on applications of photolabelling, to dozens of politicians and a panel...

CPI Collaborates with Edinburgh University on Project to Create Digital Twin

CPI has created a cutting-edge, next generation system to drive efficient learning for complex particle products. CPI, along with the expert input of its partners, has successfully coupled together two of its core projects – Models MPP and Prospect CP – to develop a novel, accessible Digital Twin. This facility creates an open-access learning environment to work against the challenges of powder mixing and granulation...

Lamellar Biomedical partners with two leading Scottish universities to further optimise its LAMELLASOME™ Nucleic Acid delivery platform

Lamellar Biomedical Limited (Lamellar), an innovative biotechnology company, pioneering new approaches for the safe and effective transfer of functional nucleic acids, announces two research partnerships to further optimise its LAMELLASOME™ Nucleic Acid technology platform and its product manufacturing processes. The partnerships are with the University of Strathclyde and Edinburgh University. Lamellar believes its LAMELLASOME NAT (Nucleic Acid Transfer) technologywill play a key role in realising the...

Scottish investment firm Kelvin Capital celebrates record year

Glasgow based investment firm reaches a key milestone by completing its biggest investment yet. Some £10.5 million was invested across nine businesses in Kelvin Capital’s portfolio, which covers sectors like internet and app technology, biotech, life sciences, electronic manufacturing and medical technologies, in 2018. The company has now entered its 10th year having secured £30.2m – made up from its syndicate members’ money, plus co-investment...

Ayrshire Growth Deal Agreed

More than £250 million growth deal set to bring jobs and opportunity to the Ayrshire region for years to come. On the 8th of March 2019, Scottish Secretary David Mundell was joined by council leaders and the Scottish Government’s Cabinet Secretary for transport, infrastructure and connectivity, Michael Matheson, to sign a transformational growth deal for Ayrshire. The deal will see the UK government invest £103...

Scotland’s Life Sciences Awards Winners Revealed

The winners of this year’s prestigious Scottish Life Sciences Awards have been announced. Held at the Edinburgh International Conference Centre on Thursday 28th February 2019 the Awards were attended by 700 of the leading players in Scotland’s dynamic life sciences sector. The Awards were supported by a raft of leading organisations including Ernst & Young, GSK, Highlands and Islands Enterprise, Merck, Piramal Pharma Solutions and...

Life science businesses secure record equity investment as industry’s stellar growth continues

Scotland’s life sciences companies raised a record £85 million of equity investment during the past year, including a surge in international venture capital support, according to new figures released by Life Sciences Scotland ahead of the industry’s annual awards ceremony. The landmark figure represents a 27% rise on the £67m investment made during the previous 12 months. Companies that have secured funding in the past year include...

Scottish Government extends genomics partnership with Neogen

Neogen Corporation (Nasdaq: NEOG) announced today the Scottish Government has formally extended its partnership with Neogen in Ayr, Scotland, to perform genomics testing as part of the government’s program to improve the country’s beef herd. The genomic testing partnership was initiated in October 2016, and now has been extended through September 2021. The Beef Efficiency Scheme (BES) is funded as part of the Scottish Rural...

Immunotherapy Company TC BioPharm partners with Trinity College Dublin to develop V delta 1 γδ T cell-based cancer treatments

TC BioPharm (TCB) today announced it is collaborating with Dublin’s Trinity College to accelerate in-house production of V delta 1 γδ T cell banks for treatment of solid tumors. The collaboration with Dublin’s School of Medicine, Trinity College, will leverage extensive experience gained by Dr Derek Doherty related to the biology and culture expansion of V delta 1 γδ T cells. Dr Doherty and his...

Top